Personal Injury/Clinical Negligence
Solicitor urges insurers to challenge non-whiplash OIC injuries
Motor insurers need to challenge the growth of non-tariff injuries among whiplash claimants in court to ensure they do not become the norm, a leading defendant solicitor has argued.
PI firm maintains huge growth of accident management business
Private-equity backed personal injury business Winn Group continues to buck the market trend, with turnover for the first half of 2023/24 up 35% to nearly £143m.
Lack of detail on clin neg fixed costs “extremely worrying”
The lack of detail in the government plans for fixed costs for lower-value clinical negligence cases is “extremely worrying”, with only six months to go to implementation.
Just a “rump” of claims companies left active in PI market
The landscape for claims management companies active in the personal injury market has changed dramatically, with just a “rump” remaining, new research has found.
Buckland: Whiplash reforms have held down motor premium rises
Insurance premiums would have risen even more without the whiplash reforms of 2021, according to the former Lord Chancellor who presided over their introduction.
Law firm AI project could provide lawyers with file summaries
A renewed artificial intelligence partnership between injury firm Fletchers and Liverpool University could see lawyers provided with summaries to help them understand files.
Acquisitions help propel fast-growing PI firm to rapid growth
The personal injury law firm aiming to become the largest in the country has had another year of major growth, despite the overall sluggishness of the market.
PI lawyers attack “premature disclosure” of OIC medical reports
The Association of Personal Injury Lawyers has condemned plans for the “premature disclosure” of medical reports on the Official Injury Claim portal.
Court rejects bid to draw listed business into its law firm’s costs dispute
A court has rejected an application for a non-party costs order against listed legal and credit hire business Anexo Group over the work of its subsidiary law firm.
Rule committee warned government over clin neg fixed fee timetable
The Civil Procedure Rule Committee warned the government in July about the difficulty of meeting the timetable for the new regime of fixed costs in low-value clinical negligence cases.
PI firm struck down by whiplash reforms sold in pre-pack deal
Another law firm to suffer following the 2021 whiplash reforms has been sold in a pre-pack administration deal to a firm that itself has just been bought up.
Listed PI business winding down joint venture ABS
NAHL – the listed business that owns National Accident Helpline – is winding down another of its joint venture alternative business structures as its own law firm goes from strength to strength.
Evidence “does not back up” insurer claims of ‘hiplash’ and ‘wristlash’
Insurer assertions that the number of mixed injury cases has risen dramatically since the launch of the Official Injury Claim portal are not borne out by the evidence, it was argued last week.
Law firms “failing to respond” to consumer enquiries
Law firms are losing business by failing to get back to potential clients, with as many as one in five enquiries going unanswered, new research shows.
Government policy to blame for OIC shortcomings, say claimant lawyers
The problems with the Official Injury Claim portal identified by the justice select committee are “not just operational, but policy driven”, claimant lawyers have argued.
Blog
Regulation, growth and access to justice: why legal services need a reset
Well-intentioned consumer protections embedded in the regulation of legal services increasingly act as barriers to innovation, competition and access to justice.
Digital marketing for law firms in 2026 – where to focus your efforts
Digital marketing for law firms in 2026 is more demanding than ever. AI is reshaping content, while audiences are becoming more selective and platforms are raising the bar on quality.
From AI ambition to operational reality
AI is no longer an emerging technology on the horizon. It has become the connective tissue binding law, regulation, risk and commercial decision-making.
